Repligen Corp

RGENNASDAQUSD
173.99 USD
0.74 (0.42%)🟢LIVE (AS OF 12:07 PM EDT)
🟢Market: OPEN

Repligen Corp (RGEN) trades at $173.99 per share. Our models show a "Strong Buy" technical signal alongside a "Neutral" fundamental rating. Key drivers include a robust Altman Z-Score, a bullish Golden Cross on the moving averages and bullish moving average alignment. Furthermore, RGEN is currently richly valued, trading at a premium to sector peers across key valuation metrics.

Technical & fundamental data as of Sep 15, 2026.

Open?$174.90
High?$178.10
Low?$172.74
Prev. Close?$174.73
Volume?202.7K
Avg. Volume?979.5K
VWAP?$174.66
Rel. Volume?0.21x
Bid / Ask
Bid?$164.56 × 100
Ask?$184.80 × 100
Spread?$20.24
Midpoint?$174.68
Valuation & Ratios
Market Cap?9.9B
Shares Out?56.4M
Float?55.9M
Float %?99.2%
P/E Ratio?237.39
P/B Ratio?4.67
EPS?$0.74
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, and other life science companies. It sells four main product categories: filtration and fluid management is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia-Pacific contribute about 44%, 37%, and 19% of revenue, respectively.
Employees
2.0K
Market Cap
9.9B
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
1986-04-29
Address
41 SEYON STREET
WALTHAM, MA 02453
Phone: (781) 449-9560
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bullish(+2/3)
Medium-Term (Wave)? Bullish(+1/3)
Short-Term (Ripple)? Bullish(+3/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
60
Z-Score?
100
Momentum?
21
Short Sent.?
49
Piotroski F-Score?5/9Mixed
Altman Z-Score?8.05Safe
Confidence?56%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?11.82%High
Short Interest?6.6M
Days to Cover?6.7
Free Float55.9M
Avg Daily Volume990.3K
Settlement Date2026-08-31
Financial Health
Current Ratio?9.05Strong
Quick Ratio?7.64Strong
Cash Ratio?4.57Strong
Debt/Equity?0.26Low
ValuationRICHLY VALUEDvs 8 peers + S&P 500
Score
39/100
P/E?
Peers
22
S&P
3
237.4PRICEY
P/B?
Peers
44
S&P
39
4.67FAIR
P/S?
Peers
11
S&P
3
12.56HIGH
P/FCF?
Peers
25
S&P
3
88.1PRICEY
EV/EBITDA?
Peers
22
S&P
3
64.8HIGH
EV/Sales?
Peers
11
S&P
7
12.49HIGH
Returns & Efficiency
ROE?
Peers
22
S&P
17
2.0%WEAK
ROA?
Peers
22
S&P
15
1.4%WEAK
Cash Flow & Enterprise
FCF?$112.0M
Enterprise Value?$9.8B
Fundamentals ratios updated end of day